| Authors: |
Maser J; Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Callans L; Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Yu D; Center for Biostatistics & Epidemiology, Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Kampman K; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., McRae-Clark A; Department of Psychiatry, Medical University of South Carolina, Charleston, SC, USA., Cunningham R; Department of Psychology, Temple University, Philadelphia, PA, USA., Walters MI; Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Tabi S; Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Lu X; Center for Biostatistics & Epidemiology, Department of Biomedical Education and Data Science, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA., Lapeyra O; Segal Trials, Behavioral Clinical Research, Inc., Miami, FL, USA., Kakar R; Segal Trials, Innovative Clinical Research, Inc. Ft. Lauderhill, FL, USA., Morrison MF; Department of Psychiatry, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA. Electronic address: mary.morrison@temple.edu. |
